When does BIOTEST AG-VORZUGSAKTIEN (BIO3.DE) report earnings?
BIOTEST AG-VORZUGSAKTIEN (BIO3.DE) will report earnings on 2025-08-04.
BIOTEST AG-VORZUGSAKTIEN (BIO3.DE) Forecast, Price Target & Analyst Ratings
FRA:BIO3 • DE0005227235
Current stock price
30 EUR
0 (0%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOTEST AG-VORZUGSAKTIEN (BIO3.DE).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of €30.00 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.71%
BIO3.DE was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about BIO3.DE.
In the previous month the buy percentage consensus was at a similar level.
BIO3.DE was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Aug 4, 2025
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 516.1M 0.10% | 684.6M 32.65% | 726.2M 6.08% | 719.12M -0.97% | |
| EBITDA YoY % growth | 19.2M 200.52% | 156.2M 713.54% | 127.2M -18.57% | 149.48M 17.52% | |
| EBIT YoY % growth | -16.6M 66.93% | 120.3M 824.70% | 86.6M -28.01% | 108.07M 24.79% | |
| Operating Margin | -3.22% | 17.57% | 11.93% | 15.03% | |
| EPS YoY % growth | N/A 47.88% | N/A | N/A | 1.52 1,600.00% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BIOTEST AG-VORZUGSAKTIEN / BIO3.DE Forecast FAQ
What is the consensus rating for BIOTEST AG-VORZUGSAKTIEN (BIO3.DE) stock?
The consensus rating for BIOTEST AG-VORZUGSAKTIEN (BIO3.DE) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.